SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-036221
Filing Date
2024-03-19
Accepted
2024-03-19 17:19:45
Documents
1
Group Members
WAYNE P. ROTHBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm249236d1_sc13da.htm SC 13D/A 33880
  Complete submission text file 0001104659-24-036221.txt   35808
Mailing Address 50 WEST 57TH ST. 15TH FLOOR NEW YORK NY 10019
Business Address 50 WEST 57TH ST. 15TH FLOOR NEW YORK NY 10019 212.554.4475
Quogue Capital LLC (Filed by) CIK: 0001361475 (see all company filings)

IRS No.: 134197137 | State of Incorp.: NY
Type: SC 13D/A

Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Subject) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85384 | Film No.: 24765027
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)